Work

Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients

Year: 2014

Type: article

Study design: Observational Study

Source: International Journal of Hematology

DOI: 10.1007/s12185-014-1611-1

Authors: Shuichiro Takashima, Toshihiro Miyamoto, Masanori Kadowaki, Yoshikiyo Ito, Takatoshi Aoki, Ken Takase, Takahiro Shima, Goichi Yoshimoto, Koji Kato, Tsuyoshi Muta, Motoaki Shiratsuchi, Katsuto Takenaka, Hiromi Iwasaki, Takanori Teshima, Tomohiko Kamimura, Koichi Akashi

Institutions: Kyushu University, National Kyushu Medical Center, Harasanshin Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science

Awards: Target TIM-3 to eradicate AML stem cells, Gene mutations in hematopoietic stem cells of chronic lymphocytic leukemia

OpenAlex ID: W2053744129

FWCI: 0.849

Cites: 16

Cited by: 9

Related to: 10